Skip to main content
. 2021 Feb 25;36(1):693–706. doi: 10.1080/14756366.2021.1890726

Table 2.

5-Chloro-2-aminopyridines CDK9 inhibitors published by GenFleet therapeutics.

  Inline graphic
Compound 9 10
R H Me
IC50 (nM)    
 CDK9/cyclin T1 0.93 1.27
 CDK2/cyclin A 6850 2860
 CDK5/p25 6950 4640
 CDK7/cyclin H 3700 1720
 Cytotoxicity* 31 30

CDK: cyclin-dependent kinase; IC50: half maximal inhibitory concentration. *Average of 11 cell lines.